Symptomtext
administered an ACT HIB however instead of using the provided and recommended diluent they used a different diluent which is sterile water for live virus vaccine with no preservatives with no reported adverse event; Initial information received on 17-Apr-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves 1 years old male patient who was administered a haemophilus type B (HIB) (PRP/T) vaccine [ACT-HIB] however instead of using the provided and recommended diluent, reporter used a different diluent which is sterile water for live virus vaccine with no preservatives with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (DTAP) for Prophylactic vaccination. On 14-Apr-2023, the patient was administered a Standard dose of 0.5 ml suspect haemophilus type B (HIB) (PRP/T) vaccine Powder and solvent for solution for injection (lot UJ739ABA, expiry date-10-AUG-2023) via intramuscular route in the left thigh for Immunization, however, instead of using the provided and recommended diluent, used a different diluent which is sterile water for live virus vaccine with no preservatives with no reported adverse event (product preparation error) (latency- same day). Caller wants to know if they need to revaccinate the patient. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.